All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 143 of 206 pages ‹ First < 141 142 143 144 145 > Last ›
HSL18075
Gottlieb S
A fifth of Americans contact their doctor as a result of drug advertising
BMJ 2003 Nov 19;325:(7369):854
http://www.bmj.com/cgi/content/full/325/7369/854/b
HSL1484
Relman A.
Your Doctor's Drug Problem
The New York Times 2003 Nov 18
http://www.nytimes.com/2003/11/18/opinion/your-doctor-s-drug-problem.html
HSL1485
White E.
Group of House Rx Reimport Backers:Seek Stronger Provision in Medicare Bill
The Bureau of National Affairs, Inc 2003 Nov 18
HSL9928
Doran E, Henry DA.
The PBS community awareness campaign: how helpful is blaming patients?
Med J Aust 2003 Nov 17;179:(10):544-5
http://www.mja.com.au/public/issues/179_10_171103/dor10622_fm.html
HSL1483
Burne J.
Just how effective are medical screening tests? More than you need to know?
The Guardian 2003 Nov 15
http://www.guardian.co.uk/society/2003/nov/15/medicineandhealth.publichealth
HSL1482
Dodge C.
FDA Won't Rule Out Action Against States Over Imports
Bloomberg 2003 Nov 14
HSL1481
Hallam K.
Bush, Retirees, Insurers Push for Medicare Measure
Bloomberg 2003 Nov 13
HSL18062
Rothman DJ
The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant by Fran Hawthorne The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers Katharine Greider
NEJM 2003 Nov 13;349:(20):1980
http://intl-content.nejm.org/cgi/content/full/349/20/1980
HSL859
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12;290:(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b
HSL1480
Wilde Mathews A, Landers P.
An FDA Shift Could Transform Market for Statins: Agency Will Consider Allowing Over-the-Counter Sales Of Cholesterol Medicine
The Wall Street Journal 2003 Nov 12
HSL12
Murray A.
Drug Makers' Paths Of Influence Need To Be Less Hidden
The Wall Street Journal 2003 Nov 11
HSL1478
Global rise in use of fake drugs
BBC News 2003 Nov 11
http://news.bbc.co.uk/2/hi/health/3261385.stm
HSL18061
Sibbald B
Alberta MDs irate over prescribing privacy issue
CMAJ 2003 Nov 11;169:(10):1066
http://www.cmaj.ca/cgi/content/full/169/10/1066
HSL1476
Picard A.
Health law may protect Ottawa
The Globe and Mail 2003 Nov 10
http://www.freedomofchoiceinhealthcare.ca/Articles/HealthCanada/healthcanada7.html
HSL1477
Sex, Drugs And Middle Age
CBC-TV 2003 Nov 10
HSL13
Mokhiber R.
Say No to Silicone
The Corporate Crime Reporter 2003 Nov 8
http://www.commandtrust.org
HSL1475
Adams P.
A dose of healthy suspicion
The Australian 2003 Nov 8
HSL9937
Bounameaux H.
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet 2003 Nov 8;362:(9395):1581
http://linkinghub.elsevier.com/retrieve/pii/S0140673603147502
HSL1473
Rowland C.
FDA mulls drug-import action: Agency says it may charge states, cities
The Boston Globe 2003 Nov 7
HSL1474
Kurt K.
Judge OKs Shutdown of Canada Drugs Firm
Associated Press 2003 Nov 7
HSL20150
Saunders B
DTCA and the cost of asthma inhalers
New Zealand Medical Journal 2003 Nov 7;116:(1185 ):
http://journal.nzma.org.nz/journal/116-1185/672/
HSL1472
Rutkowski C.
More Generic Drugs Could Cut Costs, Save Milions Each Year: Study finds that Manitoba could save significantly if generic drugs were used more often
Public Affairs Department 2003 Nov 6
HSL9943
Kloner RA, Brindis RG, Cheitlin MD, Kuritzky L, Miller TA, Padma-Nathan H, Rosen RC.
Roundtable discussion: tadalafil study group.
Am J Cardiol 2003 Nov 6;92:(9A):58M-65M
http://linkinghub.elsevier.com/retrieve/pii/S0002914903008269
HSL4476
Carter H, Mansfield P.
Eye on ads.
Australian Doctor Weekly 2003 Nov 5
HSL1470
Teske S.
Potential House-Senate Compromise On Medicare Bill Outlined in Document
The Bureau of National Affairs 2003 Nov 3
HSL1471
Mathews A.
FDA Issues Rules on New Era Of 'Personalized Medicine'
The Wall Street Journal 2003 Nov 3
HSL1469
Extensive records analyzed for series
The Miami Herald 2003 Nov 2
HSL5376
Salmon P, Hall GM.
Patient empowerment and control: a psychological discourse in the service of medicine.
Soc Sci Med 2003 Nov 01;57:(10):1969-80
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4899V1S-4&_coverDate=11%2F30%2F2003&_alid=421169285&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0108299694b7ad851b9ec164f0cf893a
HSL9938
Scott PW.
Supply of veterinary medicines.
Vet Rec 2003 Nov 1;153:(18):572
HSL18064
Chalmers I, Rounding C, Lock K.
Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.
BMJ 2003 Nov 1;327:(7422):1017
http://www.bmj.com/cgi/content/full/327/7422/1017?view=long&pmid=14593034
HSL18066
Dobson R
Industry sponsored studies twice as likely to have positive conclusions about costs
BMJ 2003 Nov 1;327:(7422):106
http://www.bmj.com/cgi/content/full/327/7422/1006-b
HSL1194
Krueger KP, Felkey BG, Berger BA.
Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative.
J Am Pharm Assoc (Wash DC) 2003 Nov-Dec;43:(6):668-78
HSL1211
Gale EA.
Between two cultures: the expert clinician and the pharmaceutical industry.
Clin Med 2003 Nov-Dec;3:(6):538-41
http://www.ingentaconnect.com/content/rcop/cm/2003/00000003/00000006/art00015?token=00681f293f7ee784b3143d54e6b63734f582a2f4876753375726f4f2858595c5f3b3b476752486b25707b514a2f425aca8359cca
HSL1802
Wager E.
Good practice in publication of clinical trial results.
Br J Psychiatry 2003 Nov;183:464-5:
http://bjp.rcpsych.org/cgi/content/full/183/5/464-a
HSL1912
Monaghan MS, Galt KA, Turner PD, Houghton BL, Rich EC, Markert RJ, Bergman-Evans B.
Student understanding of the relationship between the health professions and the pharmaceutical industry.
Teach Learn Med 2003 Win;15:(1):14-20
HSL1914
Millstein LG.
Prescription drug advertising: is it a driving force on drug pricing?
N C Med J 2003 Nov-Dec;64:(6):289-91
HSL9794
Gonzalez Hernando S, Gonzalez Mieres C, Diaz Martin AM.
Intention of purchasing generic prescription drugs on the part of consumers in Asturias, Spain
Rev Esp Salud Publica. 2003 Nov;77:(6):691-9
HSL9889
Tatara K.
Prescribing and dispensing in Japan: conflict of interest?
Clin Med 2003 Nov-Dec;3:(6):555
http://www.ingentaconnect.com/content/rcop/cm/2003/00000003/00000006/art00019?token=00561dd74219e401fad63726e2d2954496f642f466f256720297d7625627b2e7b4624246a6f7c49ac6bc4a
HSL9891
Levy C, Bonastre J.
[The cost of chemotherapy].
Bull Cancer. 2003 Nov;90:(11):976-82
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FC/CE/resume.md
HSL9895
Kardos P.
Fixed combinations as a first line treatment for all degrees of severity in asthma?
Pneumologie 2003 Nov;57:(11):671-3
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2003-44267
HSL9901
Pearson SA, Ross-Degnan D, Payson A, Soumerai SB.
Changing medication use in managed care: a critical review of the available evidence.
Am J Manag Care 2003 Nov;9:(11):715-31
http://web.archive.org/web/20041206205928/http://www.ajmc.com/article.cfm?ID=2486
HSL9902
Minhas R.
Statins: is OTC actually OTT?
Int J Clin Pract 2003 Nov;57:(9):750-1
HSL9912
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001.
Can J Cardiol 2003 Nov;19:(12):1359-66
HSL9913
Little S.
The future is personal
Current Drug Discovery 2003 Nov;9-10
HSL9930
Erasmus J.
Ritalin--on the bandwagon?
S Afr Med J 2003 Nov;93:(11):805
HSL9932
Camp SL, Wilkerson DS, Raine TR.
The benefits and risks of over-the-counter availability of levonorgestrel emergency contraception.
Contraception 2003 Nov;68:(5):309-17
http://linkinghub.elsevier.com/retrieve/pii/S0010782403002269
HSL9944
Hogan WR, Tsui FC, Ivanov O, Gesteland PH, Grannis S, Overhage JM, Robinson JM, Wagner MM; Indiana-Pennsylvania-Utah Collaboration.
Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products.
J Am Med Inform Assoc 2003 Nov-Dec;10:(6):555-62
http://www.jamia.org/cgi/content/full/10/6/555
HSL9945
Hoch I, Heymann AD, Kurman I, Valinsky LJ, Chodick G, Shalev V.
Countrywide computer alerts to community physicians improve potassium testing in patients receiving diuretics.
J Am Med Inform Assoc 2003 Nov-Dec;10:(6):541-6
http://www.jamia.org/cgi/content/full/10/6/541
HSL9950
Brass EP, Weintraub M.
Label development and the label comprehension study for over-the-counter drugs.
Clin Pharmacol Ther 2003 Nov;74:(5):406-12
http://www.nature.com/clpt/journal/v74/n5/abs/clpt2003500a.html;jsessionid=69F78644AC0571CEFD32EA375F17CA21
HSL13369
Moncrieff J, Double D.
Double blind random bluff.
Ment Health Today 2003 Nov;:24-6:
http://www.ncbi.nlm.nih.gov/pubmed/14689600
HSL16133
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship.
J Am Board Fam Pract. 2003 Nov-Dec;16:(6):513-24
http://www.jabfm.org/cgi/content/full/16/6/513
HSL1465
Evenson B.
Heart doctors redefine 'normal': Lower cholesterol, lower blood pressure now expected
National Post 2003 Oct 30
HSL1466
Petersen M.
Campaign for Medical Device Bypasses Doctors
New York Times 2003 Oct 30
http://www.nytimes.com/2003/10/30/business/the-media-business-advertising-campaign-for-medical-device-bypasses-doctors.html
HSL1467
Harris G.
Drug Makers’ New Intensity in Defense of U.S. Borders
The New York Times 2003 Oct 30
http://www.nytimes.com/2003/10/30/business/drug-makers-new-intensity-in-defense-of-us-borders.html?fta=y&archive:article_related
HSL1468
Cassels A.
Is Big Pharma pulling Canada's chain?
The Globe and Mail 2003 Oct 30
HSL14
Drug firm hit with $200-million class action: Quebecer says he was diagnosed with liver damage while on antidepressant
Montreal Gazette 2003 Oct 29
HSL15
Dougherty K .
Ottawa needs to rein in ads by drug firms: Nobody is complaining about them, Alliance says
The Gazette 2003 Oct 29
HSL1464
Biswas S.
Indian drugs boss hails Aids deal
BBC News 2003 Oct 29
http://news.bbc.co.uk/2/hi/americas/3220619.stm
HSL1462
Harris G.
F.D.A. Intensely Reviews Depression Drugs
The New York Times 2003 Oct 28
HSL1463
Foster J.
FDA advisory urges caution in children's use of antidepressants
The Herald 2003 Oct 28
HSL1444
FDA Issues Public Health Advisory Entitled: Reports Of Suicidality in Pediatric Patients Being Treated with Antidepressant Medications for Major Depressive Disorder (MDD)
2003 Oct 27
HSL1461
Kaufman M.
FDA Cautions on Antidepressants and Youth
The Washington Post 2003 Oct 27
HSL17
Davis D .
Losing the Mind: David Oaks and Others in the 'Mad Pride' Movement Believe Drugs Are Being Overused in Treating Mental Illness, and They Want the Abuse to Stop.
Los Angeles Times 2003 Oct 26
http://pqasb.pqarchiver.com/latimes/access/430966241.html?dids=430966241:430966241&FMT=ABS&FMTS=ABS:FT&type=current&date=Oct+26%2C+2003&author=David+Davis&pub=Los+Angeles+Times&edition=&startpage=I.20&desc=Losing+the+Mind
HSL1443
Kluger J.
Medicating Young Minds: Drugs have become increasingly popular for treating kids with mood and behavior problems. But how will that affect them in the long run?
The Times Online 2003 Oct 26
HSL1442
Vedantam S.
AIDS Plan Would Cut Drug Costs for Poor: WHO Would Provide 3-in-1 Pill to Nations
The Washington Post 2003 Oct 25
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&node=&contentId=A14310-2003Oct24¬Found=true
HSL9953
The statin wars: why AstraZeneca must retreat.
Lancet. 2003 Oct 25;362:(9393):1341
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/S0140-6736(03)14669-7
HSL18067
Dyer O.
Drug company and pharmacy send unsolicited samples of Prozac to Florida residents.
BMJ 2003 Oct 25;327:(7421):950
http://www.bmj.com/cgi/content/full/327/7421/950-a?view=long&pmid=14576244
HSL18072
Sidley P.
Competition body rules that drug companies
BMJ 2003 Oct 25;327:(7421):946
http://www.bmj.com/cgi/content/full/327/7421/946-a?view=long&pmid=14576226
HSL18069
Sibbald B
Rules that extend drug patents face challenge
CMAJ 2003 Oct 23;169:(9):950
http://www.cmaj.ca/cgi/content/full/169/9/950-a
HSL18
Parker-pope , T .
The Case for Hormone Therapy: Menopause hormones have been battered by recent studies highlighting their potential dangers. Here's why women might still want to take them.
The Wall Street Journal 2003 Oct 21
HSL2149
Dowden JS.
Coax, COX and cola: Manufacturers’ claims in well funded marketing campaigns cannot replace the test of time
Med J Aust 2003 Oct 20;179:(8):397-8
http://www.mja.com.au/public/issues/179_08_201003/dow10457_fm-2.html
HSL367
Sweet M.
Website launched to expose "tricks" of drug ads
BMJ 2003 Oct 18;327:(7420):936
http://bmj.bmjjournals.com/cgi/content/full/327/7420/936
HSL18068
Moynihan R.
Cochrane at crossroads over drug company sponsorship.
BMJ 2003 Oct 18;327:(7420):924-6
http://www.bmj.com/cgi/content/full/327/7420/924?view=long&pmid=14563759
HSL5476
Mansfield PR.
Drug company sponsorship would endanger health care improvement
BMJ 2003 Oct 17;327:
http://bmj.bmjjournals.com/cgi/eletters/327/7420/924
HSL19
Drug incentive schemes under fire: Pharmaceutical firms accused of overstepping advertising rules
NetDoctor.co.uk 2003 Oct 15
HSL18074
Sibbald B.
Canadian media say DTC pharma ads the right Rx.
CMAJ 2003 Oct 14;169:(8):822
http://www.cmaj.ca/cgi/content/full/169/8/822-a
HSL1440
Hensley S.
Court Revives Suit Against Pfizer On Nigeria Study
The Wall Street Journal 2003 Oct 13
HSL1441
Klein N.
Bush's Aids 'gift' has been seized by industry giants: Now the US may block the provision of cheap generic drugs for Africa
The Guardian 2003 Oct 13
http://www.guardian.co.uk/world/2003/oct/13/wto.aids
HSL3807
Brett AS, Burr W, Moloo J.
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians
Archives of Internal Medicine 2003 Oct 13;163:(18):2213-2218
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14557219
HSL10237
Weeks RL.
Separation of anxiety and depressive disorders: normal rules of critical evaluation were presumably suspended.
BMJ 2003 Oct 11;327:(7419):869
http://www.bmj.com/cgi/content/full/327/7419/869-a
HSL18070
Hopkins Tanne J
FDA chief wants other rich countries to share drug development costs
BMJ 2003 Oct 11;327:(7419):830
http://www.bmj.com/cgi/content/extract/327/7419/830-d
HSL18071
Bonaccorso S, Sturchio JL
What information do patients need about medicines? Perspectives from the pharmaceutical industry.
BMJ 2003 Oct 11;327:(7419):863
http://www.bmj.com/cgi/content/full/327/7419/863?view=long&pmid=14551109
HSL1439
The Community News Department at CKUT Radio McGill announces... "Pharmed and Dangerous: the Pharmaceutical Industry in Canada"
2003 Oct 10
HSL4477
Saunders C.
New web site targets drug ads.
Australian Doctor Weekly 2003 Oct 10
HSL1437
Andrews E.
Senate Panel Backs Bill to Give Tax Windfall to U.S. Companies
The New York Times 2003 Oct 2
http://www.nytimes.com/2003/10/02/business/02TAX.html
HSL1438
Dobbs L.
Over-medication: a growing crisis Aggressive marketing a major culprit
Tribune Media Services 2003 Oct 2
HSL1435
Nilson asks Ottawa to reject pharmaceutical ads
CBC Saskatchewan 2003 Oct 1
HSL1436
Boseley S.
Scientist in rethink over drug link to suicide
The Guardian 2003 Oct 1
HSL10241
Bross PF, Baird A, Chen G, Jee JM, Lostritto RT, Morse DE, Rosario LA, Williams GM, Yang P, Rahman A, Williams G, Pazdur R.
Fulvestrant in postmenopausal women with advanced breast cancer.
Clin Cancer Res 2003 Oct 1;9:(12):4309-17
http://clincancerres.aacrjournals.org/cgi/content/full/9/12/4309
HSL422
Mansfield PR.
Healthy scepticism.
Aust Fam Physician 2003 Oct;32:(10):777
HSL1238
Booth B, Zemmel R.
Quest for the best.
Nat Rev Drug Discov 2003 Oct;2:(10):838-41
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrd/journal/v2/n10/abs/nrd1203_fs.html&dynoptions=doi1114941377
HSL1906
Peebles ME.
And now, a word from our sponsor.
Harv Bus Rev 2003 Oct;81:(10):31-5
HSL2329
Mizik M, Jacobsen R
Are Physicians Easy Marks?: Quantifying the effects of Detailing and Sampling on New Prescriptions.
Unpublished 2003 Oct;
HSL2333
Prosser H, Walley T.
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
Fam Pract 2003 Oct;20:(5):583-91
http://fampra.oxfordjournals.org/cgi/content/full/20/5/583
HSL9940
Finucane AK.
From the Epilepsy Foundation: restoring the Pediatric Rule.
Epilepsy Behav 2003 Oct;4:(5):453-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WDT-4979HJH-3&_user=10&_coverDate=10%2F31%2F2003&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=037a849c55b3c7b3773bce79f4cc3873
HSL9951
Wang YR, Pauly MV, Lin YA.
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.
Am J Manag Care 2003 Oct;9:(10):686-96
http://www.ncbi.nlm.nih.gov/pubmed/14572179
HSL9952
Grabowski H.
The ripple effects of a restrictive Medicaid formulary.
Am J Manag Care 2003 Oct;9:(10):648-9
http://www.ajmc.com/Article.cfm?ID=2470&CFID=8980495&CFTOKEN=81996035
HSL10244
Martin A, Leslie D.
Trends in psychotropic medication costs for children and adolescents, 1997-2000.
Arch Pediatr Adolesc Med 2003 Oct;157:(10):997-1004
http://archpedi.ama-assn.org/cgi/content/full/157/10/997
HSL10245
Dominick KL, Dudley TK, Grambow SC, Oddone EZ, Bosworth HB.
Racial differences in health care utilization among patients with osteoarthritis.
J Rheumatol 2003 Oct;30:(10):2201-6
HSL10248
Spina E, Scordo MG, D'Arrigo C.
Metabolic drug interactions with new psychotropic agents.
Fundam Clin Pharmacol 2003 Oct;17:(5):517-38
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1472-8206.2003.00193.x
Page 143 of 206 pages ‹ First < 141 142 143 144 145 > Last ›
